Ratings by BTIG (Maria Thibault)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 2/5/2026 | Accuray | ARAY | Maintain | Buy (N/A) |
|
Details | ||
| 12/16/2025 | Outset Medical Inc. | OM | Maintain | Buy (Buy) |
|
Details | ||
| 11/11/2025 | Outset Medical Inc. | OM | Maintain | Buy (N/A) |
|
Details | ||
| 11/6/2025 | Accuray | ARAY | Maintain | Buy (N/A) |
|
Details | ||
| 8/14/2025 | Accuray | ARAY | Maintain | Buy (N/A) |
|
Details | ||
| 6/6/2025 | Accuray | ARAY | Maintain | Buy (N/A) |
|
Details | ||
| 6/4/2025 | Outset Medical Inc. | OM | Maintain | Buy (N/A) |
|
Details | ||
| 3/21/2025 | Outset Medical Inc. | OM | Maintain | Buy (N/A) |
|
Details | ||
| 1/22/2025 | Outset Medical Inc. | OM | Maintain | Buy (N/A) |
|
Details | ||
| 5/2/2024 | Accuray | ARAY | Maintain | Buy (N/A) |
|
Details | ||
| 4/8/2024 | Outset Medical Inc. | OM | New Coverage | Buy (N/A) |
2.05 (3.18) |
55.12% | Details | |
| 3/20/2023 | Pear Therapeutics | PEAR | Downgrade | Neutral (Buy) |
0.59 (0.03) |
-94.92% | Details | |
| 1/28/2021 | Accuray | ARAY | Maintain | Buy (N/A) |
|
Details | ||
| 1/21/2020 | Accuray | ARAY | Upgrade | Buy (Neutral) |
3.28 (0.49) |
-85.06% | Details |
